Autophagy modulation as a potential therapeutic target for diverse diseases

Nat Rev Drug Discov. 2012 Sep;11(9):709-30. doi: 10.1038/nrd3802.

Abstract

Autophagy is an essential, conserved lysosomal degradation pathway that controls the quality of the cytoplasm by eliminating protein aggregates and damaged organelles. It begins when double-membraned autophagosomes engulf portions of the cytoplasm, which is followed by fusion of these vesicles with lysosomes and degradation of the autophagic contents. In addition to its vital homeostatic role, this degradation pathway is involved in various human disorders, including metabolic conditions, neurodegenerative diseases, cancers and infectious diseases. This article provides an overview of the mechanisms and regulation of autophagy, the role of this pathway in disease and strategies for therapeutic modulation.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Autophagy / drug effects*
  • Autophagy / physiology
  • Communicable Diseases / drug therapy
  • Communicable Diseases / epidemiology
  • Drug Delivery Systems / methods*
  • Drug Delivery Systems / trends
  • Humans
  • Neurodegenerative Diseases / drug therapy
  • Neurodegenerative Diseases / epidemiology
  • Pharmaceutical Preparations / administration & dosage*
  • Signal Transduction / drug effects*
  • Signal Transduction / physiology

Substances

  • Pharmaceutical Preparations